pulmonarylung
fibrosi
fibros
alveol
irrevers
accumul
connect
tissu
interstiti
airway
lung
pathogenesi
pulmonari
fibrosi
complex
remain
poorli
understood
addit
lung
fibrosi
result
mani
patholog
process
includ
idiopath
interstiti
pneumonia
ipf
bestknown
entiti
infect
malign
surgic
procedur
wide
believ
genet
factor
play
import
role
aetiopathogensi
mani
pulmonari
fibrot
disord
also
evid
develop
fibros
lung
diseas
occur
suscept
individu
multipl
genet
loci
exert
variabl
rel
small
effect
involv
transform
growth
multifunct
cytokin
play
role
sever
biolog
process
associ
suscept
variou
diseas
contribut
influx
activ
inflammatori
cell
epitheli
mesenchym
transdifferenti
cell
influx
fibroblast
subsequ
elabor
extracellular
matrix
furthermor
transform
growth
factor
polymorph
present
higher
express
also
shown
associ
increas
invas
breast
cancer
date
singlenucleotid
polymorph
snp
shown
affect
express
similarli
play
central
role
pulmonari
fibrosi
chemotact
fibroblast
induc
synthesi
matrix
protein
glycoprotein
inhibit
collagen
degrad
induct
proteas
inhibitor
reduct
metalloproteas
light
relev
develop
fibrosi
larg
number
studi
conduct
investig
associ
polymorph
develop
pulmonari
fibrosi
studi
shown
posit
associ
tt
genotyp
pulmonari
fibrosi
develop
anoth
studi
found
cc
genotyp
risk
factor
suscept
ipf
studi
perform
metaanalysi
evalu
associ
polymorph
pulmonari
fibrosi
search
pubm
medlin
embas
scupo
wanfang
novemb
studi
evalu
associ
polymorph
pulmonari
fibrosi
human
use
follow
search
term
pulmonari
fibrosi
lung
fibrosi
alveol
fibros
fibros
alveolitid
genet
polymorph
genet
variat
genet
variant
polymorph
variant
transform
growth
factor
refer
cite
relev
articl
produc
search
also
manual
search
possibl
miss
inclus
avoid
potenti
public
bia
place
limit
public
date
public
type
sampl
origin
countri
languag
studi
approv
ethic
committe
nanj
univers
tradit
chines
medicin
written
inform
consent
obtain
subject
inclus
criteria
literatur
follow
casecontrol
design
patient
diagnos
pulmonari
fibrosi
accord
highresolut
comput
tomographi
hrct
lung
biopsi
diagnosi
idiopath
pulmonari
fibrosi
base
offici
american
thorac
societi
at
andor
european
respiratori
societi
er
statement
provid
adequ
summari
statist
genet
variant
investig
polymorph
pulmonari
fibrosi
includ
idiopath
pulmonari
fibrosi
pulmonari
fibrot
diseas
could
caus
sever
acut
respiratori
system
sar
emphysema
cystic
fibrosi
cryptogen
fibros
alveol
exclus
criteria
studi
report
overlap
data
b
studi
incomplet
data
c
studi
duplic
data
data
check
extract
investig
independ
follow
inform
extract
elig
studi
whenev
avail
first
author
public
year
sampl
size
control
case
group
mean
age
sex
ratio
ethnic
geograph
locat
diagnost
tool
pulmonari
fibrosi
idiopath
pulmonari
fibrosi
genotyp
frequenc
disagr
resolv
discuss
among
author
consensu
reach
metaanalysi
perform
use
review
manag
revman
softwar
copenhagen
nordic
cochran
centr
cochran
collabor
stata
program
stata
softwar
packag
version
colleg
station
tx
relationship
polymorph
pf
assess
determin
pool
or
ci
allel
vs
c
homozygot
comparison
tt
vs
cc
domin
tt
vs
tc
cc
recess
cc
vs
tc
tt
model
randomeffect
use
estim
pool
or
ci
heterogen
found
statist
signific
set
threshold
level
betweenstudi
heterogen
evalu
use
statist
rang
valu
quantifi
betweenstudi
variabl
present
owe
random
chanc
follow
distribut
low
heterogen
moder
heterogen
larg
heterogen
consider
heterogen
surpass
threshold
warrant
use
addit
metaanalysi
techniqu
subgroup
analysi
metaregress
explain
varianc
studi
public
bia
examin
mean
eggger
linear
regress
test
rank
correct
test
figur
display
strategi
literatur
search
comprehens
literatur
search
total
studi
initi
retriev
includ
duplic
record
review
abstract
nondupl
studi
remov
studi
due
follow
reason
studi
pulmonari
fibrosi
n
abstract
n
origin
research
articl
n
review
n
meet
report
n
metaanalysi
n
remain
studi
one
studi
exclud
fulltext
articl
avail
remov
studi
follow
reason
provid
detail
inform
case
control
n
studi
associ
pulmonari
fibrosi
n
provid
reusabl
data
n
snp
report
fewer
find
omit
select
owe
insuffici
data
process
result
applic
studi
cover
one
snp
current
analysi
follow
snp
exclud
owe
limit
public
insuffici
data
figur
show
literatur
search
studi
select
process
total
potenti
public
identifi
search
term
perform
onlinedatabas
subsequ
literatur
screen
process
retain
public
relev
human
subject
casecontrol
studi
suffici
report
data
variant
nonprimari
research
paper
review
metaanalysi
manual
survey
remov
snp
report
fewer
find
omit
select
owe
insuffici
data
remain
filter
step
preced
inclus
exclus
criteria
strictli
appli
process
result
applic
studi
cover
one
elig
snp
suitabl
public
publish
sampl
size
rang
tabl
describ
detail
characterist
studi
includ
sampl
size
studi
origin
ethnic
pf
diagnosi
measur
origin
diseas
mean
age
studi
geograph
conduct
china
korea
britain
spain
saudi
arabia
pulmonari
fibrosi
patient
diagnos
either
hrct
andor
biopsi
regard
origin
diseas
studi
differ
other
wei
et
al
eigamel
et
al
includ
pulmonari
fibrosi
patient
nonipf
diseas
wherea
rest
studi
involv
patient
diagnos
ipf
make
diagnosi
idiopath
pulmonari
fibrosi
studi
use
follow
diagnost
criteria
american
thorac
societi
european
respiratori
societi
japanes
respiratori
societi
latin
american
thorac
associ
consensu
statement
studi
mean
age
case
found
around
year
half
includ
studi
agematch
control
alhamad
et
al
xaubet
et
al
use
younger
peopl
control
wei
et
al
eigamel
et
al
provid
age
sex
inform
patient
averag
maletofemal
ratio
found
case
control
respect
two
studi
differ
other
regard
sex
ratio
li
et
al
son
et
al
includ
much
less
femal
patient
studi
regard
origin
diseas
studi
other
wei
et
al
eigamel
et
al
includ
sar
pretranspl
pulmonari
fibrosi
respect
remain
studi
enrol
ipf
patient
figur
tabl
summar
result
metaanalysi
overal
signific
associ
found
polymorph
pulmonari
fibrosi
comparison
model
use
odd
ratio
confid
interv
ci
model
follow
allel
comparison
model
vs
c
homozygot
comparison
model
tt
vs
cc
domin
genet
model
tt
vs
tc
cc
recess
model
tt
tc
vs
cc
rule
effect
ethnic
origin
diseas
subsequ
perform
subgroup
analysi
statist
signific
associ
polymorph
pf
ethnic
diseas
subgroup
tabl
except
trend
frequenc
pulmonari
fibrosi
less
genotyp
tt
genotyp
respect
homozygot
comparison
model
tt
vs
cc
ci
domin
model
tt
vs
tc
cc
ci
among
asian
similarli
pattern
seen
idiopath
pulmonari
fibrosi
patient
ci
homozygot
domin
model
respect
figur
tabl
show
public
bia
comparison
model
model
present
obviou
public
bia
calcul
begg
egger
test
p
associ
polymorph
suscept
variou
diseas
autoimmun
diseas
infecti
diseas
cancer
previous
report
given
fact
level
blood
injur
lung
higher
patient
pulmonari
fibrosi
healthi
control
multipl
studi
report
conflict
result
regard
associ
polymorph
pulmonari
fibrosi
best
knowledg
first
comprehens
metaanalysi
evalu
associ
gene
polymorph
pulmonari
fibrosi
develop
although
studi
report
associ
metaanalysi
find
polymorph
associ
suscept
pulmonari
fibrosi
present
find
consist
gener
trend
variou
pulmonari
fibrosi
genet
studi
attribut
polygenet
natur
disord
subgroup
analysi
public
bia
test
p
provid
addit
support
robust
result
eigamel
et
al
first
report
role
polymorph
pretranspl
allograft
lung
fibrosi
found
distribut
allel
similar
normal
healthi
control
group
lung
transplant
recipi
pulmonari
fibrosi
son
et
al
found
tt
genotyp
posit
associ
idiopath
pulmonari
fibrosi
develop
p
li
et
al
demonstr
proport
subject
cc
genotyp
signific
higher
idiopath
pulmonari
fibrosi
group
control
group
subject
howev
sever
studi
could
find
notic
associ
polymorph
pulmonari
fibrosi
metaanalysi
includ
patient
healthi
control
independ
studi
confirm
absenc
associ
polymorph
risk
pulmonari
fibrosi
develop
inconsist
might
attribut
small
size
studi
includ
metaanalysi
maximum
number
patient
pulmonari
fibrosi
case
report
wei
et
al
publish
year
data
patient
sar
recoveryrel
lung
fibrosi
use
analysi
lack
associ
might
also
attribut
polygen
contribut
disord
mean
individu
gene
contribut
modest
effect
collect
cumul
effect
likelihood
develop
ill
perform
subgroup
analys
ethnic
origin
diseas
exclud
potenti
sourc
heterogen
among
includ
studi
howev
could
find
statist
signific
associ
subgroup
analysi
slightli
less
frequenc
pulmonari
fibrosi
observ
among
ipf
patient
tt
genotyp
p
might
attribut
singl
studi
report
rel
strong
associ
rather
low
frequenc
genotyp
ipf
patient
gener
metaanalysi
sever
limit
merit
consider
studi
first
lack
broader
coverag
investig
polymorph
relat
pulmonari
fibrosi
risk
thu
hinder
abil
conduct
wider
spectrum
analysi
encompass
snp
present
metaanalysi
abl
collect
data
one
studi
snp
perform
effect
size
calcul
relev
snp
implic
pulmonari
fibrosi
suscept
one
exampl
snp
associ
fibrosi
lung
transplant
recipi
locu
omit
analysi
owe
lack
suffici
studi
ie
studi
provid
reusabl
genet
inform
second
casecontrol
design
studi
popul
stratif
analysi
often
necessari
warrant
sampl
case
control
share
common
genet
characterist
snp
interest
thu
result
may
hamper
shortcom
exampl
studi
provid
smoke
statu
inform
subject
differ
smoke
ratio
particular
import
sinc
smoke
peopl
like
predispos
pulmonari
fibrosi
owe
lack
genotyp
inform
smoke
statu
unabl
subgroup
analysi
third
view
rel
small
sampl
size
limit
studi
number
especi
subgroup
nonipf
diseas
studi
includ
power
use
detect
real
differ
case
control
may
strong
final
pf
multifactori
diseas
potenti
interact
factor
may
influenc
process
pf
conclus
studi
found
exist
literatur
suggest
associ
polymorph
pulmonari
fibrosi
consid
polygen
effect
pulmonari
fibrosi
larg
number
casecontrol
studi
inform
relat
genet
polymorph
could
provid
reliabl
evid
role
polymorph
respect
suscept
pulmonari
fibrosi
conceptu
lili
xin
miao
jiang
data
curat
lili
xin
miao
jiang
guangbao
su
methodolog
lili
xin
miao
xie
hui
chen
xiao
liu
supervis
jien
gong
valid
lili
xin
miao
jiang
guangbao
su
miao
xie
hui
chen
xiao
liu
jien
gong
write
origin
draft
lili
xin
write
review
edit
muge
xu
geng
zhang
conceptu
lili
xin
data
curat
lili
xin
miao
jiang
guangbao
su
methodolog
lili
xin
miao
xie
hui
chen
supervis
jien
gong
valid
lili
xin
xiao
liu
write
origin
draft
lili
xin
write
review
edit
jien
gong
muge
xu
geng
zhang
